PTDM is common following solid organ transplantation and is an important risk marker for early and late graft failure, and early and late mortality. Immediate post-transplant hyperglycemia requires active monitoring and management with insulin therapy, and if persistent once the patient is medically stable, there may be an opportunity to reduce or stop insulin and introduce oral hypoglycaemic therapy. Once PTDM is established, treatment targets and pathways should be as for type 2 diabetes. For more details please contact us! 9811459842.
